Evan Sussman is the co-founder and CEO of Granata Bio, a Boston-based biopharma company expanding access to fertility care by in-licensing IVF medications proven abroad and bringing them through U.S. clinical development and commercialization. A former fertility business unit head at EMD Serono, he built Granata to be revenue-positive early through a fee-for-service model, then raised a $14M Series A led by GV (Google Ventures), extended it, acquired ovarian-aging biotech Oviva Therapeutics, and struck a strategic investment and co-development deal with Gedeon Richter.
Sunfish is a Los Angeles fertility fintech that helps people pay for and navigate IVF, egg freezing, surrogacy and donor journeys. It pairs a loan marketplace and all-inclusive, flat-fee treatment bundles with a partial money-back guarantee, an AI model that predicts cycle cost and outcomes from patient biodata, and human and emotional support. Founded in 2022 by Angela Rastegar after her own isolating fertility experience, the company has supported over $200 million in loan applications across all 50 states and works with 70+ clinic locations.
Evvy is a precision women's health company building the first AI-powered vaginal healthcare platform around a CLIA-certified, at-home metagenomic vaginal microbiome test. Founded in 2021 by Stanford alums Priyanka Jain and Laine Bruzek, Evvy pairs state-of-the-art testing that screens for 700+ bacteria and fungi with clinician-reviewed results, personalized prescription treatment, and one-on-one health coaching. By generating one of the largest datasets on female biomarkers, Evvy aims to close the gender health gap - starting with conditions like bacterial vaginosis that have been chronically under-researched.
Lyman Stone is a demographer who has become one of the most-quoted voices on why people are having fewer babies. He directs the Pronatalism Initiative at the Institute for Family Studies and serves as Director of Research at Demographic Intelligence, where he builds forecasting models of fertility and family formation. A Kentuckian economist turned population scientist, he completed his PhD at McGill University and is a fixture in the New York Times, Wall Street Journal, and on podcasts like Modern Wisdom, arguing that falling birth rates are less about money and more about marriage, meaning, and the things people want but never get around to.
Alife Health is a San Francisco-based health technology company building AI-powered software for IVF clinics. Its platform helps embryologists grade embryos, helps reproductive endocrinologists time ovarian stimulation, and helps clinics streamline scheduling and patient communication - all aimed at improving outcomes and lowering the cost of fertility care.
Mira is a women's health company that built the first at-home hormone monitor with lab-grade accuracy. Its connected device, single-use wands and AI-powered app measure FSH, LH, estrogen (E3G) and PdG so users can map fertility windows, manage PCOS, navigate menopause and share clinical-grade data with their doctors.
Vivoo is a San Francisco-based health tech company that makes at-home urine test strips analyzed via smartphone camera. Founded in 2017, the company offers a wellness platform that measures 8+ biomarkers — including hydration, vitamins, minerals, pH, ketones, and oxidative stress — and delivers personalized nutrition and lifestyle recommendations through a free mobile app. Backed by $19.4M in funding led by Tim Draper, Vivoo is sold at Target, Walmart, and Sam's Club, and has expanded to 100+ countries with a focus on making lab-grade health insights accessible to everyday consumers.
Noor Siddiqui is the founder and CEO of Orchid Health, a San Francisco-based biotech startup offering whole-genome sequencing for IVF embryos, screening for 1,200+ genetic variants. Motivated by watching her mother lose her sight to retinitis pigmentosa, she dropped out of high school at 17 to become one of the youngest Thiel Fellows, later returned to earn dual CS degrees at Stanford, and then built Orchid with $16.5M in funding from investors including 23andMe founder Anne Wojcicki and Coinbase's Brian Armstrong. She is also the host of the podcast 'Conceivable with Noor.'
Sylvia Kang is the CEO and co-founder of Mira (Miracare), the company behind the world's first FDA and CE-registered comprehensive at-home hormone monitoring platform. A former concert pianist who pivoted to biomedical engineering, she built Mira from her kitchen table into a 140-person company with 200,000+ users worldwide and over 50,000 women helped to conceive naturally. Named to Inc. Magazine's 2024 Female Founders 250 list and Femtech World's Leader of the Year, Kang holds an MS in Biomedical Engineering from Columbia and an MBA from Cornell, and used her own product to conceive after age 35.
Paxton Maeder-York is the founder of Alife Health, an AI platform for IVF clinics that has raised $31.5M and raised the standard for data-driven fertility care. A Harvard-trained biomedical engineer and MBA, he previously helped build surgical robotics at Auris Health (acquired by J&J for $3.4B) and worked in product at Google X. In 2020, driven in part by the fact that his younger brother is an IVF baby, he founded Alife to apply machine learning to embryo selection, hormone dosing, and lab scheduling. By 2024 the company had launched five products, earned recognition from Fast Company and the World Economic Forum, and achieved a leadership transition - Paxton stepping into a board role as Melissa Teran took the CEO seat.
Preethi Kasireddy is a serial founder, engineer, and educator who pivoted from Goldman Sachs investment banking to venture capital at Andreessen Horowitz, then taught herself to code at Hack Reactor and went on to build at Coinbase, found TruStory, create DappCamp - one of the most respected Web3 developer bootcamps - and most recently co-found Ferta, a root-cause fertility coaching startup. Her writing on Ethereum and blockchain architecture has become essential reading for tens of thousands of developers worldwide.